Featured Research

from universities, journals, and other organizations

Metabolites' role in understanding disease emphasized

Date:
April 3, 2014
Source:
University of Alabama in Tuscaloosa
Summary:
Over-reliance on genetic-centered approaches in predicting, diagnosing and treating disease will lead to few future scientific breakthroughs, cautioned a researcher who co-authored an article that advocates for a greater emphasis on the body's metabolites in understanding illnesses. "To augment the value of genetic data, the scientific community needs to add additional information from things like metabolomics -- the analysis of metabolites within an organism," said the lead author.

Over-reliance on genetic-centered approaches in predicting, diagnosing and treating disease will lead to few future scientific breakthroughs, cautioned a University of Alabama researcher who co-authored an article in an early online issue of Genetics that advocates for a greater emphasis on the body's metabolites in understanding illnesses.

"To augment the value of genetic data, the scientific community needs to add additional information from things like metabolomics -- the analysis of metabolites within an organism," said Dr. Laura Reed, a University of Alabama geneticist and the March 25 paper's lead author.

"The Human Genome Project has been sold as something that is going to revolutionize medicine -- that soon we will get our genomes sequenced, and we will be able to figure out exactly what diseases we are at risk for and, maybe, the best way to treat them," said Reed. "While it's true there are important innovations to come from that kind of information, it is much more limited than some may have hoped."

Using fruit flies as animal models in the research publishing in Genetics, the multi-institution team demonstrated how genetics, in combination with metabolomics and gene expression -- how genes are turned on -- can be used to predict heart disease and the organism's response to environmental change, said Reed.

The paper's additional co-authors include representatives from Georgia Tech, Sanford-Burnham Medical Research Institute, La Jolla, Calif.; North Carolina State University; Huck Institutes of the Life Sciences, University Park, Pa.; and Bayer CropScience, Monheim, Germany.

Metabolites are naturally occurring chemicals in the body. While a few, like cholesterol and blood glucose are routinely monitored for the insights they can provide into health conditions, additional metabolites merit closer inspection, the researchers said. Glycine, a metabolite which serves as both an essential amino acid and a neurotransmitter, has previously been shown as a predictor of heart disease and certain cancers.

"We identified another nine metabolites that are also good predictors that have not yet been previously described as associated with these traits," Reed said. "They are good candidates for exploring further. They may not be causal, but they may be correlated."

One day, Reed said, in addition to doctors measuring blood glucose and cholesterol levels, perhaps they will routinely measure other metabolites as way of improving predictions of disease risks.

In one of the project's aspects, headed by UA, 187 metabolites were measured in flies to determine which ones' levels changed in correlation with weight changes in the flies.

As with mice and other widely accepted animal models used in studying human conditions, many of the biological systems within fruit flies share enough similarities with humans to potentially draw effective insight into human conditions, Reed said. For example, flies can contract diabetes and, as they age, heart disease. Their insulin-signaling pathways, key in diabetes, share similarities with those of humans, as do their kidneys, liver and the adipose tissue -- the types of tissue where fat is stored.

Hundreds of genetically identical flies, grouped by 20 distinct genetic lines, were tested across four different diets. In this way, the researchers are able to determine which aspect of their disease is because of their genes and which aspect is because of their environment or diet.

"One of the important things we found is that the effects of diet are relatively small for gene expression, but much more significant for all the metabolites."

In another aspect of the research, led by Georgia Tech, the scientists tracked how the frequency of genes in wild flies changed through time (over multiple generations) in response to diet. Rather than seeing changes in one particular gene or a small group of genes, the researchers saw changes across the entire genome.

"We can't expect to find a gene or just a few genes that explain any phenotype, including disease," Reed said. Disease is a holistic problem, she said, and it's unlikely that additional "miracle drugs" await discovery.

"It's going to be a holistic solution," Reed said.

Reed said she realizes the paper may not be warmly embraced by all her fellow geneticists.

"The overall point of the paper is not a very popular idea," Reed admitted, "because it basically means things are much more complicated than we want them to be. But, that's reality.

"This does not mean that we can't incrementally improve things by understanding the genes that are involved, but, perhaps, a more expedient approach would be analyzing higher level traits, like metabolites, that might summarize what's occurring in the genome in ways more useful for diagnostic or treatment purposes."


Story Source:

The above story is based on materials provided by University of Alabama in Tuscaloosa. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. K. Reed, K. Lee, Z. Zhang, L. Rashid, A. Poe, B. Hsieh, N. Deighton, N. Glassbrook, R. Bodmer, G. Gibson. Systems Genomics of Metabolic Phenotypes in Wild-Type Drosophila melanogaster. Genetics, 2014; DOI: 10.1534/genetics.114.163857

Cite This Page:

University of Alabama in Tuscaloosa. "Metabolites' role in understanding disease emphasized." ScienceDaily. ScienceDaily, 3 April 2014. <www.sciencedaily.com/releases/2014/04/140403095419.htm>.
University of Alabama in Tuscaloosa. (2014, April 3). Metabolites' role in understanding disease emphasized. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140403095419.htm
University of Alabama in Tuscaloosa. "Metabolites' role in understanding disease emphasized." ScienceDaily. www.sciencedaily.com/releases/2014/04/140403095419.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins